Enanta Pharma (ENTA) Tops Q4 EPS by 14c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. FISV
10. CVS

Go back to Enanta Pharma (ENTA) Tops Q4 EPS by 14c

Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2015

November 23, 2015 4:01 PM EST

Conference Call and Webcast Today at 4:30 p.m. ET

Royalty revenue of $14.4 million in fourth quarter brings fiscal year total to $34.1 million AbbVies phase 3 trial begun for next-generation HCV treatment containing Enantas protease inhibitor ABT-493 Enantas cyclophilin inhibitor candidate EDP-494 expected to enter the clinic in the first calendar quarter of 2016 Cash and marketable securities totaled $209 million at September 30, 2015

WATERTOWN, Mass.--(BUSINESS WIRE)-- Enanta Pharmaceuticals, Inc., (NASDAQ:... More